Characteristics, perceived side effects and benefits of electronic cigarette use: A worldwide survey of more than 19,000 consumers

International Journal of Environmental Research and Public Health

Volumn 11, Issue 4, 2014, Pages 4356-4373

  Farsalinos, Konstantinos E ^a   Romagna, Giorgio ^b   Tsiapras, Dimitris ^a   Kyrzopoulos, Stamatis ^a   Voudris, Vassilis ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b Biological and Chemical Toxicology Research Institute   (Italy)

Author keywords

Electronic cigarette; Harm reduction; Nicotine; Public health; Smoking; Tobacco

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE;

CONSUMPTION BEHAVIOR; HEALTH IMPACT; PUBLIC HEALTH; QUESTIONNAIRE SURVEY; RESPIRATORY DISEASE; SMOKING;

ADULT; ALLERGY; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSUMER; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DIZZINESS; DRY THROAT; DYSPNEA; ELECTRONIC CIGARETTE USE; EPISTAXIS; FEMALE; GINGIVA BLEEDING; GINGIVITIS; GLOSSITIS; HAIRY TONGUE; HARM REDUCTION; HEADACHE; HEALTH STATUS; HEALTH SURVEY; HEART PALPITATION; HUMAN; INSOMNIA; MALE; MEDICAL DEVICE; MOUTH INFLAMMATION; MOUTH PAIN; ONLINE SYSTEM; PASSIVE SMOKING; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SMOKING; SOMNOLENCE; SORE THROAT; THORAX PAIN; TOBACCO; XEROSTOMIA;

ADULT; ELECTRICAL EQUIPMENT AND SUPPLIES; HUMANS; MALE; MIDDLE AGED; PERCEPTION; QUESTIONNAIRES; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84899138644     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110404356     Document Type: Article

References (28)

1. Moore, D.; Aveyard, P.; Connock, M.; Wang, D.; Fry-Smith, A.; Barton, P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009, 338, doi:10.1136/bmj.b1024
2. Rigotti, N.A.; Pipe, A.L.; Benowitz, N.L.; Arteaga, C.; Garza, D.; Tonstad, S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: A randomized trial. Circulation 2010, 121, 221-229
3. Rodu, B.; Godshall, W.T. Tobacco harm reduction: An alternative cessation strategy for inveterate smokers. Harm Reduct. J. 2006, 3, doi:10.1186/1477-7517-3-37
4. Farsalinos, K.E.; Romagna, G.; Tsiapras, D.; Kyrzopoulos, S.; Voudris, V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst. Abuse 2013, 7, 139-146
5. Dawkins, L.; Turner, J.; Roberts, A.; Soar, K. 'Vaping' profiles and preferences: An online survey of electronic cigarette users. Addiction 2013, 108, 1115-1125
6. Etter, J.F.; Bullen, C. Electronic cigarette: Users profile, utilization, satisfaction and perceived efficacy. Addiction 2011, 106, 2017-1028
7. Popova, L.; Ling, P.M. Alternative tobacco product use and smoking cessation: A national study. Am. J Public Health 2013, 103, 923-930
8. Vickerman, K.A.; Carpenter, K.M.; Altman, T.; Nash, C.M.; Zbikowski, S.M. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob. Res. 2013, 15, 1787-1791
9. Bullen, C.; Howe, C.; Laugesen, M.; McRobbie, H.; Parag, V.; Williman, J.; Walker, N. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet 2013, 382, 1629-1637
10. Caponnetto, P.; Campagna, D.; Cibella, F.; Morjaria, J.B.; Caruso, M.; Russo, C.; Polosa, R. Efficiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS ONE 2013, 8, doi:10.1371/journal.pone.0066317
11. Vansickel, A.R.; Cobb, C.O.; Weaver, M.F.; Eissenberg, T.E. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": Nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomarkers Prev. 2010, 19, 1945-1953
12. Etter, J.F. Levels of saliva cotinine in electronic cigarette users. Addiction 2014, doi:10.1111/add.12475
13. Farsalinos, K.; Spyrou, A.; Tsimopoulou, K.; Stefopoulos, C.; Romagna, G.; Voudris, V. Nicotine absorption from electronic cigarette use: Comparison between first and new-generation devices. Sci. Rep. 2014, doi:10.1038/srep04133
14. Goniewicz, M.L.; Lingas, E.O.; Hajek, P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: An internet survey. Drug Alcohol Rev. 2013, 32, 133-140
15. Fagerström, K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob. Res. 2012, 14, 75-78
16. Farsalinos, K.E.; Romagna, G.; Tsiapras, D.; Kyrzopoulos, S.; Spyrou, A.; Voudris, V. Impact of flavour variability on electronic cigarette use experience: An internet survey. Int. J. Environ. Res. Public Health 2013, 10, 7272-7282
17. Dawkins, L.; Corcoran, O. Acute electronic cigarette use: Nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl.) 2014, 231, 401-407
18. Nides, M.A.; Leischow, S.J.; Bhatter, M.; Simmons, M. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am. J. Health Behav. 2014, 38, 265-274
19. European Commission. Revision of the Tobacco Products Directive-Press Release (European Parliament)2013. Available online: http://www.europarl.europa.eu/pdfs/news/expert/infopress/20131216IPR31001/20131216IPR31001_en.pdf (accessed on 28 December 2013)
20. European Commission. Fact Sheets for Information on Specific Policy Areas of the Revision of the Tobacco Products Directive: E-Cigarettes 2013. Available online: http://ec.europa.eu/health/ tobacco/docs/fs_ecigarettes_en.pdf (accessed on 28 December 2013)
21. Mayer, B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch. Toxicol. 2014, 88, 5-7
22. Goniewicz, M.L.; Knysak, J.; Gawron, M.; Kosmider, L.; Sobczak, A.; Kurek, J.; Prokopowicz, A.; Jablonska-Czapla, M.; Rosik-Dulewska, C.; Havel, C.; Jacob, P., III; Benowitz, N. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 2013, doi:10.1136/tobaccocontrol-2012-050859
23. Williams, M.; Villarreal, A.; Bozhilov, K.; Lin, S.; Talbot, P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013, 8, doi:10.1371/journal.pone.0057987
24. Romagna, G.; Allifranchini, E.; Bocchietto, E.; Todeschi, S.; Esposito, M.; Farsalinos, K.E. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): Comparison with tobacco cigarette smoke extract. Inhal. Toxicol. 2013, 25, 354-361
25. Farsalinos, K.E.; Romagna, G.; Allifranchini, E.; Ripamonti, E.; Bocchietto, E.; Todeschi, S.; Tsiapras, D.; Kyrzopoulos, S.; Voudris, V. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int. J. Environ. Res. Public Health 2013, 10, 5146-5162
26. Etter, J.F.; Bullen, C. A longitudinal study of electronic cigarette users. Addict. Behav. 2014, 39, 491-494
27. Farsalinos, K.E.; Stimson, G.V. Is there any legal and scientific basis for classifying electronic cigarettes as medications? Int. J. Drug Policy 2014, doi:10.1016/j.drugpo.2014.03.003
28. Centers for Disease Control and Prevention (CDC). Notes from the field: Electronic cigarette use among middle and high school students-United States, 2011-2012. MMWR Morb. Mortal. Wkly. Rep. 2013, 62, 729-730.